Aptalis Pharma, Inc.

597 Sir-Wilfrid-Laurier Boulevard,
Mont-Saint-Hilaire, Quebec J3H 6C4

Aptalis is a leading multinational specialty pharmaceutical company. The Company develops and markets a broad line of prescription products used to treat gastrointestinal diseases and disorders.

Aptalis Pharma was acquired by Forest Laboratories on January 08, 2014.

Join Mergr to view all 209 acquisitions of medical products companies in 2014, including 20 acquisitions by private equity firms, and 189 by strategics.

Out of 60 sectors in the Mergr database, medical products ranked 14 in number of deals in 2014. The largest medical products acquisition in 2014 was Covidien - which was acquired by Medtronic for $42.9B.

Join Mergr to view this profile - and discover more medical products acquisitions of companies like Aptalis Pharma.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.